In this article (publisehd in a high quality journal that is the 1st / 2nd in its respective SCI category) a new family of lightweight protocols for security and privacy provisioning is presented. It is intended for medical body area networks in e-health environments. Beside, deployment of trust management methods is analyzed for this purpose.
COBISS.SI-ID: 10091092
nformation about muscle composition is essential for scientific and professional purpose. It could be used for more efficient traning plans, rehab methods, sport or physical activity selection, therefore more suitable to each person. We have developd a non-invasive method for estimation of muscle composition, to avoid biopsy.
COBISS.SI-ID: 1992147
Asthma is a heterogeneous disease, and asthmatic patients without rhinitis more commonly have fi xed airway obstruction, a feature that is also typical of chronic obstructive pulmonary disease (COPD). The Dutch hypothesis suggests that both COPD and asthma have common genetic risk factors. The purpose of this study was to assess the association between the polymorphism rs4795405 in the known asthma candidate gene ORMDL3 and asthma with and without rhinitis. We also analyzed COPD in order to investigate whether, in addition to a clinical overlap, there might also be a genetic overlap between COPD and asthma. The population of this genetic association study comprised 493 Slovenian adults, distributed as follows: 131 patients with asthma (59 had asthma with rhinitis and 72 asthma without rhinitis), 59 patients with rhinitis only, 133 patients with COPD, and 170 controls. Genotypes for rs4795405 were determined using the TaqMan genotyping assay. rs4795405 was specifically associated with asthma without rhinitis. Assuming a recessive genetic model, we found the CC genotype in 26% of healthy controls, in 24% of patients with asthma with rhinitis (P=.862), and in 44% of patients with asthma without rhinitis (P=.006). Polymorphism rs4795405 was also associated with COPD, for which the CC genotype was found in 37% of cases (P=.045). rs4795405 was strongly associated with asthma without rhinitis, a subtype of asthma for which a higher degree of airway obstruction was found. These results show the importance of analyzing different asthma phenotypes in genetic association studies. We also observed a genetic overlap between COPD and asthma without rhinitis.
COBISS.SI-ID: 36819717
In manuscript under No 1 we proposed a nonivasive method for assessment of skeletal muscle composition. In this manuscript we published reliability analysis of the same method. We found that reliability is high enough for a valid use of the method and longitudinal comparison.
COBISS.SI-ID: 2212307
Background: Lately, the world’s biggest Professional Services company has recognized that mHealth is enabling and accelerating three major global trends in healthcare: regulatory reform driven by demographic changes, industrialization of the healthcare sector and personalized medicine. They have identified interoperability as a key enabler of scalable mHealth. Continua Health Alliance is a non-profit organization that globally certifies mobile health solutions. They publish interoperability guidelines for connecting health related devices. Unfortunately, the adoption of these guidelines has not been consistent. Problem: We want to define a platform and a framework to support the development of different e&m-health interventions for various domains. The solution has to support sharing of information between interventions within the system and also with external systems in a standardized way. Methodology: In the chapter we describe an approach towards interoperability that was achieved in several different aspects. First, the enterprise interoperability is supported by using IHE profiles.. Second, organizational interoperability is supported by use of BPMN2; and third, the semantic interoperability is supported by using OpenEHR, MLHIM and standard terminologies and vocabularies. Results: We built the platform that permits iterative incremental development process of new interventions. The developed interventions are fully interoperable within e&m-health environments. On the platform we deployed five different interventions that were also clinically tested. In this chapter we describe eDiabetes intervention in greater detail. Besides, we give guidelines on how to develop and deploy a new intervention.